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Current prevalence pattern of tobacco
smoking in Nigeria: a systematic review
and meta-analysis
Davies Adeloye1,2* , Asa Auta3*, Ademola Fawibe4, Muktar Gadanya5, Nnenna Ezeigwe6, Rex G. Mpazanje7,
Mary T. Dewan7, Chiamaka Omoyele6, Wondimagegnehu Alemu8, Michael O. Harhay9,10 and Isaac F. Adewole11
Abstract
Background: National smoking cessation strategies in Nigeria are hindered by lack of up-to-date epidemiologic
data. We aimed to estimate prevalence of tobacco smoking in Nigeria to guide relevant interventions.
Methods: We conducted systematic search of publicly available evidence from 1990 through 2018. A random-
effects meta-analysis and meta-regression epidemiologic model were employed to determine prevalence and
number of smokers in Nigeria in 1995 and 2015.
Results: Across 64 studies (n = 54,755), the pooled crude prevalence of current smokers in Nigeria was 10.4% (9.0–
11.7) and 17.7% (15.2–20.2) for ever smokers. This was higher among men compared to women in both groups.
There was considerable variation across geopolitical zones, ranging from 5.4% (North-west) to 32.1% (North-east) for
current smokers, and 10.5% (South-east) to 43.6% (North-east) for ever smokers. Urban and rural dwellers had
relatively similar rates of current smokers (10.7 and 9.1%), and ever smokers (18.1 and 17.0%). Estimated median age
at initiation of smoking was 16.8 years (IQR: 13.5–18.0). From 1995 to 2015, we estimated an increase in number of
current smokers from 8 to 11 million (or a decline from 13 to 10.6% of the population). The pooled mean cigarettes
consumption per person per day was 10.1 (6.1–14.2), accounting for 110 million cigarettes per day and over 40
billion cigarettes consumed in Nigeria in 2015.
Conclusions: While the prevalence of smokers may be declining in Nigeria, one out of ten Nigerians still smokes
daily. There is need for comprehensive measures and strict anti-tobacco laws targeting tobacco production and
marketing.
Keywords: Smoking, Tobacco, Prevalence, Non-communicable diseases, Risk, Nigeria
Introduction
Smoking is a leading cause of preventable deaths and
morbidity, linked to high burden of lung cancer, chronic
obstructive pulmonary disease (COPD), ischemic heart
diseases and stroke [1–3]. It accounts for more than 7
million deaths annually with about 10% of these
resulting from second-hand smoke [2]. There are
around 1.1 billion smokers worldwide and about 80%
of these live in low- and middle-income countries
(LMICs), where more than two-thirds of smoking-
related deaths occur [2].
Though global current smoking rates among adults
decreased from 23.5 to 20.7% between 2007 and 2015
[4], this reduction was largely due to the declining smok-
ing rates in Northern and Western Europe, North Amer-
ica and the Western Pacific regions [3, 4], where
considerable measures have been implemented to tackle
tobacco smoking. Conversely, smoking rate appears to
be increasing in the Middle East and Africa [4]. For ex-
ample, in sub-Saharan Africa, the consumption of to-
bacco increased by 57% between 1990 and 2009 [5]. A
recent analysis of the Demographic Health Survey data
of 30 sub-Saharan African countries revealed higher
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smoking rates, with prevalence as high as 37.7% among
men in Sierra Leone [6].
Nigeria is the most populous country in Africa and
has one of the leading tobacco markets in Africa, with
over 18 billion cigarettes sold annually costing Niger-
ians over US$ 931 million [7, 8]. Following the 2003
World Health Organization (WHO) Framework Con-
vention on Tobacco Control (FCTC) [2], Nigeria rati-
fied the convention agreement in 2005, and in 2015
signed into law the National Tobacco Control (NTC)
Act that regulates all aspects of tobacco control includ-
ing advertising, packaging, and smoke-free areas [2].
Despite these initiatives, some reports suggest the
prevalence of smoking in the country is rising at about
4% per year [8].
The WHO estimated about 13 million smokers in
Nigeria in 2012 [7], with over 16,000 deaths attribut-
able to smoking [9]. Increased commerce by inter-
national tobacco companies and the relative role they
play in economic growth may have contributed to a
rise in smoking rates [8, 10]. Although, some national
estimates of smoking prevalence have been reported
[11, 12], the exact number of smokers remains de-
bated, which possibly hinders health policy. Concerns
over current estimates include varying case defini-
tions, representativeness of study samples or data, and
poor study designs. We therefore conducted a com-
prehensive systematic search of the literature and
synthesized data based on standard case definitions to
estimate national and sub-national prevalence of
smoking in Nigeria.
Methods
This is a review of publicly available studies and con-
ducted as part of series on the epidemiology of non-
communicable diseases (NCDs) in Nigeria. Methods
have been described in detail in previous studies [13–
16]. No ethical approval was required. Study was con-
ducted in line with the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) guide-
lines [17].
Search strategy
We searched MEDLINE, EMBASE, Global Health and
Africa Journals Online (AJOL) on 31 January 2019.
We initially searched for epidemiological studies on
smoking in Nigeria and sourced for unpublished re-
ports (or studies) from Google searches and Google
Scholar. We included studies that were (i) population-
based, (ii) reporting on the prevalence of smoking
(current or ever) in a Nigerian setting, and (iii) pub-
lished on or after 01 January 1990. Search terms are
presented in the Additional file 1.
Case definitions
We selected studies that defined smoking as “smoking of
tobacco products, be it cigarettes, bidi, cigar, hookah,
pipe, or other related manufactured products and hand
rolled stuffs”. We defined current smoker as someone
who smokes every day, or some days in the last 30 days
preceding an interview. An ex-smoker (or former
smoker) is someone who was an every-day smoker or
has smoked at least 100 cigarettes in his or her lifetime
but has currently quit smoking [2, 18, 19]. An ever
smoker is defined as anyone who has quit smoking
(smoked at least 100 cigarettes in their lifetime) or cur-
rently smokes. This describes life-time smoking status
and satisfies the definition of either a current or former
smoker [19, 20].
Data extraction
DA and AA independently reviewed and assessed studies
using a pre-defined guideline to ensure consistency in
studies’ selection (disagreements were resolved by con-
sensus). From each study, we extracted number of
smokers, sample size, mean (or median) age, and esti-
mated prevalence of smoking (and confidence intervals
(CI). These were matched to the study period, site, geo-
political zone and setting, respectively. Quality of studies
was assessed during data extraction, adapting a previ-
ously used guideline [21–24]. This was based on repre-
sentativeness of the sample, appropriate design and
analysis, and standard case definitions, with each study
graded as high, moderate, or low (Additional file 1).
Data analysis
We employed a random-effects meta-analysis, using
the DerSimonian and Laird Method [25], to combine
individual study estimates and generate national and
sub-national pooled estimates of the prevalence of to-
bacco smoking in Nigeria. Assuming a binomial (or
Poisson) distribution, we estimated standard errors
from crude prevalence and sample. Heterogeneity was
identified from subgroup analyses, and assessed using
I-squared (I2) statistics. To show trends and changes
in smoking prevalence in the country, a meta-
regression model accounting for the study period, and
age was developed. Age-adjusted prevalence estimates
were generated from the model for years 1995 and
2015. These were employed to estimate the absolute
number of current and ever smokers in Nigeria based
on the United Nations population (five-year age
groups) for Nigeria for the two years [26]. This model
has been described in detail in previous studies [13–
16]. All statistical analyses were conducted on Stata
(Stata Corp V.14, Texas, USA).
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Results
Search results
A total of 1474 records were retrieved from the data-
bases – 546 studies in MEDLINE, 654 in EMBASE, 229
in Global Health, and 45 in AJOL. Twenty-two studies
were identified from additional searches. We screened
967 titles were for relevance (i.e. epidemiologic studies
on smoking in Nigeria) after removing duplicates, with
794 articles excluded. Abstracts and full-texts of the
remaining 173 articles were accessed and screened. We
retained 64 studies for synthesis (Fig. 1).
Study characteristics
The 64 studies covered the six geopolitical zones of
Nigeria (Table 1). The South-west returned 40.6% (26
studies) of all selected articles, followed by South-south
(19%, 12 studies), and South-east and North-central
(13%, 8 studies). The North-west was covered in four
studies (6.3%), while the North-east had the lowest
coverage with two studies (3.1%). Most studies (77.1%,
43 studies) were conducted in urban settings, while rural
settings had 10 studies (15.6%), and 11 studies (17.2%)
were from mixed urban and rural settings. Using our
quality criteria, 25 studies (39%) were rated as high qual-
ity, and 39 (61%) rated as moderate. All studies were
conducted under one year, with study year ranging from
1990 to 2017. The total population covered from all se-
lected studies was 54,755, with the mean (or median)
age of samples ranging from 15 to 55.5 years (Table 1
and Additional file 1). Heterogeneity was high across
studies, with I-squared (I2) estimated at 98.2%
(P < 0.001). This was generally high (I2> 95%) across
subgroups (ie. sex, geopolitical zones, geographical set-
tings) (Table 2).
Prevalence of tobacco smoking in Nigeria
Current smokers
The prevalence of current smokers ranged from 1.2% re-
corded in Yaba Lagos, South-west Nigeria in 2015 [44],
to 55.5% in Amassoma Delta State, South-south Nigeria,
also in 2015 [69]. The pooled crude prevalence of
current smokers in Nigeria was 10.4% (95% CI: 9.0–
11.7), with this significantly lower among women (3.6%,
2.8–4.4), compared to men (13.4%, 10.0–16.8) (Table 2).
Following a sensitivity analysis, the prevalence of current
smokers in the general population at 8.8% (7.5–10.2)
Fig. 1 Flow chart of selection of studies on tobacco smoking in Nigeria
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was comparable to the overall pooled estimate (10.4%),
while a higher estimate was reported among specific
populations (eg. commercial drivers, soldiers, and
healthcare students) at 17.3% (11.5–23.1) (Fig. 2). Across
the geopolitical zones, the prevalence rate of current
smokers was significantly higher in the North-east
(32.1%, 30.0–34.1), compared to the other five geopolit-
ical zones. The South-south region had a prevalence of
13.0% (8.7–17.3), North-central 10.3% (6.0–14.4), South-
west 8.9% (6.9–11.0), South-east 8.6% (4.1–13.0) and
North-west 5.4% (3.7–7.2) (Table 2). There was relatively
no difference in the prevalence of current smokers
across geographical settings, with the urban and
rural settings having a prevalence of 10.7% (8.8–
12.6) and 9.1% (5.1–13.0), respectively (Table 2 and
Additional file 1).
Ever smokers
The lowest prevalence of ever smokers was recorded in
Ibadan Oyo State, South-west Nigeria in 2009 at 2.1%
[77], while the highest was reported in Amassoma Delta
State, South-south Nigeria in 2015 at 64.6% [69]. The
pooled crude prevalence of ever smokers (i.e. life-time
prevalence of smoking) was 17.7% (95% CI: 15.2–20.2)
Fig. 2 Crude prevalence rate of current smokers in Nigeria
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(Table 2). As observed among current smokers, the
prevalence was significantly higher among men at 22.8%
(17.5–28.2), compared to women at 6.3% (4.8–7.7)
(Table 2). When population characteristics were consid-
ered in the sensitivity analysis, the prevalence of ever
smokers in the general population was 15.3% (12.9–
17.6), which was comparable to the overall estimate
(17.7%), in contrast to a relatively higher estimate among
specific population groups at 30.7% (17.7–43.7) (Fig. 3).
The pooled prevalence of ever smokers was highest in
the North-east at 43.6% (31.5–55.7), with lowest re-
corded in the South-east at 10.5% (3.7–17.4) and the
North-west at 12.4% (7.9–16.9). The South-south and
South-west have a relatively similar pooled prevalence
rates of ever smokers at 16.9% (11.4–22.3) and 17.1%
(12.8–21.4), respectively. The pooled prevalence was
minimally higher in urban settings at 18.1% (14.6–
21.6) compared to rural settings at 16.8% (10.8–22.8)
(Table 2).
Age at initiation of smoking
Most studies reported the mean or median age at initi-
ation of smoking during adolescence, with this ranging
from 12 years in Ibadan Oyo State, South-west Nigeria
[55], to 21.9 years in Lagos Mainland, South-west
Nigeria [72]. From all studies, the estimated median age
Fig. 3 Crude prevalence rate of ever smokers in Nigeria
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at initiation of smoking was 16.75 years (interquartile
range: 13.5–18.0).
Estimated number of current and ever smokers in Nigeria
Based on the model, the age-adjusted prevalence of
current smokers decreased with advancing age, while the
prevalence increased with advancing age for ever
smokers (Table 3). Using the United Nations demo-
graphic projections for Nigeria, we estimated about 8
million current smokers in Nigeria in 1995 among per-
son aged 15 years or more, with this increasing to about
11 million current smokers by 2015. The age-adjusted
prevalence of current smokers actually decreased from
13.0 to 10.6% over this period (Table 3). On the con-
trary, both the prevalence and number of ever smokers
increased over the same period, from about 10.9 million
(17.6%) in 1995 to 19.8 million (19.2%) in 2015 (Table
3).
Cigarettes consumed per day
Among current smokers, the mean cigarettes consumed
per person per day ranged from 2 (1.0–3.4) recorded in
a semi-urban setting in Abraka Delta State, South-south
Nigeria [31], to 23.7 (21.3–26.1) in a rural area in Oyo
State, Nigeria [81]. The pooled mean cigarettes con-
sumption per person per day from all studies was 10.1
(6.1–14.2) (Table 3, Fig. 4). When considered in terms
of the absolute number of current smokers in Nigeria in
2015 (11 million), this accounts for about 110 million
cigarettes per day and over 40 billion cigarettes in
Nigeria in 2015.
Discussion
This study integrated smoking information from 64
moderate to high-quality studies to estimate the current
prevalence of smoking in Nigeria. Although the preva-
lence of ever smokers increased between 1995 and 2015,
we observed a decreasing prevalence of current smokers
over the same period. This trend is in contrast to esti-
mates reported, albeit based on limited data, in some
countries insub-Saharan Africa, who have experienced
rising smoking rates due to changing socio-economic
status, rural-urban migration and increased cigarette af-
fordability [91]. The decreasing smoking rates in Nigeria
possibly reflect increased health risk awareness and bet-
ter overall measures to help smokers quit in the country.
For example, in a national survey, Kale and colleagues
[92] reported that in the 12 months preceding their
study, almost half of current smokers attempted to quit
smoking, with over two-thirds of these receiving advice
from care providers and counselors.
Despite the declining rates, we estimated about 11 mil-
lion current smokers (10.6%) and 20 million ever
smokers (19.2%) in 2015, which are still unacceptably
high from an absolute perspective. In a nation-wide sur-
vey in 2012 [11], the prevalence of current smokers was
4% among adults Nigerians. This is much lower than es-
timated in this study, presumably due to challenges with
sampling and case ascertainment. In a recent scoping ex-
ercise, Adeoye et al. [93] estimated a prevalence of
current smokers at 19.7%. However, this estimate was
not age-standardized, and a lower prevalence of ever
smokers reported raises concerns on the quality of data.
However, in 2015, the WHO reported a current smoking
prevalence of about 9% among persons aged 15 years or
more (17% among men and 1% among women) in
Nigeria [7]. The overall prevalence and sex distribution
are almost as reported in the current study. The higher
smoking prevalence among men in Nigeria is well-
documented [10, 93]. This perhaps represents a sus-
tained pattern of smoking epidemic, and presents a valu-
able opportunity for developing effective policies and
interventions learning from actions in developing coun-
tries [94, 95].
The median age at initiation of smoking in this study
(16.8 years) is relatively low, reflective of a growing bur-
den among adolescents and youths. Kale and colleagues
[92] in their nation-wide survey noted that about two-
thirds of the population started smoking before attaining
20 years. Adeoye et al. [93] reported lower age at initi-
ation of 14.7 years in the country. Many have advocated
for stiffer anti-tobacco laws in the country, particularly
Table 3 Absolute number of current and ever smokers in
Nigeria, aged 15 years or more, 1995 and 2015
Age
(years)
Current smokers Ever smokers
1995 2015 1995 2015
% n (000) % n (000) % n (000) % n (000)
15–24 13.8 1633.5 11.4 2127.4 16.1 1913.7 17.7 3291.8
20–24 13.5 1316.7 11.2 1791.6 16.5 1610.6 18.1 2897.3
25–29 13.3 1039.7 11.0 1543.5 17.0 1327.3 18.6 2608.4
30–34 13.1 861.6 10.8 1302.2 17.4 1147.4 19.0 2299.3
35–39 12.9 711.4 10.5 1051.7 17.9 988.1 19.4 1940.0
40–44 12.6 582.5 10.3 800.8 18.3 843.4 19.9 1543.4
45–49 12.4 483.1 10.1 605.9 18.7 729.1 20.3 1220.0
50–54 12.2 405.7 9.9 492.4 19.2 638.2 20.7 1035.7
55–59 12.0 321.7 9.6 399.5 19.6 527.3 21.2 877.9
60–64 11.7 245.3 9.4 312.9 20.0 418.8 21.6 718.7
65–69 11.5 177.7 9.2 234.6 20.5 316.1 22.0 563.0
70–74 11.3 116.4 9.0 163.2 20.9 215.6 22.5 409.5
75–79 11.1 64.3 8.7 94.1 21.3 124.1 22.9 246.9
80+ 10.7 37.8 8.4 60.5 22.0 77.8 23.6 170.4
All 13.0 7997.4 10.6 10,980.3 17.6 10,877.3 19.2 19,822.3
Note: Estimates based on the epidemiologic modelling from all datapoints
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to address a growing use of tobacco products among
youths [11].
The prevalence of smokers was notably higher in
North-east Nigeria which may be expected given an on-
going armed conflict lasting more than a decade. Al-
though the evidence of the association between smoking
and conflict is limited and inconclusive [96], varying so-
cial situations among vulnerable populations are known
to precipitate substance use [97]. With several persons
displaced, children and adolescents out of school, and
youths without jobs, substance use, including tobacco
products, is likely to increase in these settings. Although
Kale and colleagues [92] reported South-easterners as
the highest consumers of tobacco products in the coun-
try, the deviance from our estimates suggests a need for
more research to understand regional variations.
Although the NTC Act was signed into law in 2015
and the country has committed to the WHO FCTC
since 2005 [18], Nigeria is not yet on track to achieve to-
bacco control targets [98]. For example, our estimates
show that rural dwellers smoke almost at the same rate
as urban dwellers, indicating that smoking, believed to
be associated with urbanization, has gradually penetrated
remote areas. Further, we estimated that current
smokers consume an average of 10 cigarettes per person
per day accounting for about 110 million cigarettes per
day and over 40 billion cigarettes in 2015 alone. Vellios
et al. [99] noted that the demand for cigarettes increased
by 44% across many African countries between 1990 and
2012, with this leading to over 100% increase in ciga-
rettes production over the same period in these coun-
tries. A thriving tobacco market raises serious public
health concerns, particularly for a country with a rela-
tively weak health system. Tobacco companies see these
countries as emerging markets due to weak tobacco con-
trol regulations and several vulnerable populations [91,
94]. Careful incorporation of the WHO MPOWER pack-
age (targeted at reversing tobacco epidemic) [18] beyond
the national level to state and local levels may comple-
ment successful measures like smoke-free legislation,
taxes, health education and media campaigns [2, 7]. Be-
sides, Nigeria needs to develop comprehensive surveil-
lance systems to monitor the production, sales, and
consumption of cigarettes to effectively achieve control
targets [99].
The strength of this review lies in the number of stud-
ies retained (64) and population covered (54755), which
spread across all geopolitical zones in the country.
Herein, we have perhaps addressed an issue bordering
on representativeness, which appears to be a leading
concern in the understanding of the epidemiology of
smoking in Nigeria [10]. We acknowledge that pooling
prevalence rates from a range of studies conducted over
a 27-year period (1990–2017) could affect reliability of
our overall estimates; however, this was mainly done to
understand the trend in smoking rates over this period,
which our model and age-adjusted estimates clearly re-
flect (Table 3). Nonetheless, our estimates should be
considered with the high heterogeneity reported. This
perhaps could be due to diverse population characteris-
tics, particularly those contributed by specific population
groups. Our sensitivity analysis may have addressed this
(ie. comparing general to specific populations), as ex-
cluding some of specific populations with higher preva-
lence of smoking could imply missing some necessary
information on the use of tobacco and related products
in the country. Varying study designs are also important
sources of heterogeneity. Due to data limitations, we
could not investigate other sources of heterogeneity, in-
cluding socio-economic status, wealth index, employ-
ment status and religion. Finally, there were only two
studies from the North-east, this should guide interpret-
ation of the high estimates in the region.
Conclusion
While the prevalence of current smokers may be declin-
ing in Nigeria, the absolute number of active smokers
remain one of the highest in Africa. Economic growth,
improved socio-economic status, rapid migration, and
increased cigarette affordability are key factors. As rural
Fig. 4 Pooled mean cigarettes consumed per person per day in Nigeria
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dwellers are almost as affected as urban dwellers, careful
consideration is required during programming. Compre-
hensive measures and strict anti-tobacco laws targeting
tobacco production and marketing need to be enforced
across country levels.
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